Nektar Therapeutics Ratios (2010-2026) | NKTR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	72.94%	78.69%	75.36%	78.59%	76.30%	78.95%	71.70%	67.31%	65.88%	48.51%	69.51%	48.22%	58.53%	81.62%	70.51%	-65.01%	100.00%	100.00%	273.71%	29.09%
EBT Margin (Quarter)	-441.80%	-520.02%	-582.39%	-363.66%	-736.47%	-250.60%	-256.75%	-634.81%	-249.62%	-190.10%	-171.03%	-170.23%	-222.73%	-153.57%	24.00%	-443.30%	-352.53%	-297.04%	-159.13%	-396.74%
EBIT Margin (Quarter)	-389.00%	-455.82%	-451.48%	-469.58%	-708.07%	-229.85%	-238.25%	-623.83%	-246.84%	-185.82%	-140.30%	-163.72%	-211.90%	-142.37%	49.18%	-425.76%	-324.21%	-268.63%	357.46%	-359.58%
EBITDA Margin (Quarter)	-444.05%	-455.82%	-451.48%	-373.73%	-744.62%	-229.85%	-238.25%	-628.84%	-253.14%	-185.82%	-140.30%	-172.30%	-223.31%	-142.37%	49.18%	-486.65%	-372.67%	-268.63%	357.46%	-359.58%
Operating Margin (Quarter)	-389.00%	-455.82%	-451.48%	-469.58%	-708.07%	-229.85%	-238.25%	-623.83%	-246.84%	-185.82%	-140.30%	-163.72%	-211.90%	-142.37%	49.18%	-425.76%	-324.21%	-268.63%	357.46%	-359.58%
Net Margin (Quarter)	-443.06%	-520.47%	-582.37%	-364.16%	-736.94%	-249.94%	-271.03%	-634.52%	-249.39%	-189.85%	-171.49%	-170.07%	-222.93%	-153.61%	24.85%	-443.80%	-350.85%	-296.76%	-159.27%	-397.33%
FCF Margin (Quarter)	-304.21%	-417.61%	-629.51%	-373.16%	-351.04%	-351.61%	-264.34%	-242.42%	-252.13%	-174.59%	-197.97%	-222.03%	-161.30%	-184.87%	-159.88%	-468.98%	-409.62%	-414.55%	-297.96%	-408.03%
Efficiency
Inventory Average (Quarter)	15.71M	14.97M	15.57M	15.59M	16.17M	18.01M	19.13M	19.72M	20.46M	17.91M	15.62M	16.17M	15.35M
Assets Average (Quarter)	1,413.96M	1,324.30M	1,197.22M	1,070.65M	943.05M	821.50M	745.80M	636.17M	528.01M	468.26M	420.14M	397.02M	369.67M	325.65M	305.91M	280.05M	231.89M	254.44M	290.88M	521.84M
Equity Average (Quarter)	949.74M	853.26M	740.52M	643.70M	533.31M	435.48M	389.43M	303.75M	218.91M	178.16M	145.18M	128.85M	103.20M	64.29M	54.81M	37.24M	-5.24M	30.44M	87.46M	333.02M
Invested Capital (Quarter)	904.98M	801.54M	679.51M	607.89M	458.73M	412.22M	366.64M	240.87M	196.96M	159.37M	130.99M	126.70M	79.69M	48.88M	60.74M	13.74M	-24.21M	85.09M	89.83M	576.22M
Asset Utilization Ratio (Quarter)	0.07	0.08	0.09	0.10	0.10	0.12	0.12	0.14	0.17	0.19	0.21	0.23	0.25	0.29	0.32	0.31	0.32	0.25	0.19	0.11
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.66	0.63	0.61	0.59	0.53	0.53	0.52	0.43	0.40	0.36	0.33	0.32	0.23	0.16	0.20	0.05	-0.12	0.28	0.32	0.75
Times Interest Earned (Quarter)
Valuation
Enterprise Value (Quarter)	-1000.07M	-921.08M	-733.96M	-667.02M	-619.32M	-546.39M	-504.98M	-456.83M	-409.43M	-372.66M	-303.62M	-289.24M	-271.24M	-244.50M	-255.23M	-218.63M	-175.90M	-270.21M	-245.75M	-568.60M
Return Ratios
Return on Sales (Quarter)	-0.04%	-0.05%	-0.06%	-0.04%	-0.07%	-0.02%	-0.03%	-0.06%	-0.02%	-0.02%	-0.02%	-0.02%	-0.02%	-0.02%	0.00%	-0.04%	-0.04%	-0.03%	-0.02%	-0.04%
Return on Capital Employed (Quarter)	-33.78%	-37.48%	-40.12%	-46.95%	-59.17%	-59.20%	-55.51%	-68.42%	-61.19%	-67.92%	-71.48%	-47.71%	-52.37%	-59.31%	-43.02%	-54.66%	-62.78%	-52.15%	-14.53%	-6.25%
Return on Invested Capital (Quarter)	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.02%	-0.01%	-0.02%	-0.02%	-0.02%	-0.03%	0.19%	-0.03%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%
Return on Equity (Quarter)	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.02%	-0.01%	-0.02%	-0.03%	-0.02%	-0.03%	0.22%	-0.04%	-0.02%	0.00%

Research Tools

Developers

Nektar Therapeutics Ratios (2010-2026) | NKTR

Research Tools

Developers

Nektar Therapeutics Ratios (2010-2026) | NKTR

Create an account

Sign In

Reset Password